NEW YORK (GenomeWeb) – A steep decline in the broader biotechnology space dragged down shares of life science omics tools and molecular diagnostic firms in September. 

Compared to August, the GenomeWeb Index fell nearly 8 percent last month, following a similar nearly 8 percent drop month over month in August. Of the 31 companies comprising the index, just two, NanoString Technologies and Hologic, registered month-over-moth gains in September.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.